Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109253) titled 'Recognizing Efficacy and Safety of Syrup Nephrogrit in Patients with Chronic Kidney Disease (CKD)' on April 23.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Case Record Numbers Blinding and masking:Not Applicable
Primary Sponsor: Vrind Formulations Pvt Ltd
Condition:
Health Condition 1: N181- Chronic kidney disease, stage 1
Recruitment Status: Not Recruiting
Phase: Phase 2
Date of First Enrollment: 04-05-2026
Target Sample Size: 150
Countries of Recruitment:
India
To know more, visit http:/...